Success Metrics

Clinical Success Rate
90.9%

Based on 20 completed trials

Completion Rate
91%(20/22)
Active Trials
1(4%)
Results Posted
20%(4 trials)
Terminated
2(7%)

Phase Distribution

Ph phase_3
3
11%
Ph early_phase_1
1
4%
Ph not_applicable
11
41%
Ph phase_1
4
15%
Ph phase_4
4
15%
Ph phase_2
4
15%

Phase Distribution

5

Early Stage

4

Mid Stage

7

Late Stage

Phase Distribution27 total trials
Early Phase 1First-in-human
1(3.7%)
Phase 1Safety & dosage
4(14.8%)
Phase 2Efficacy & side effects
4(14.8%)
Phase 3Large-scale testing
3(11.1%)
Phase 4Post-market surveillance
4(14.8%)
N/ANon-phased studies
11(40.7%)

Highest Phase Reached

Phase 4

Trial Status & Enrollment

Completion Rate

90.9%

20 of 22 finished

Non-Completion Rate

9.1%

2 ended early

Currently Active

1

trials recruiting

Total Trials

27

all time

Status Distribution
Active(1)
Completed(20)
Terminated(2)
Other(4)

Detailed Status

Completed20
unknown4
Terminated2
Recruiting1

Development Timeline

Analytics

Development Status

Total Trials
27
Active
1
Success Rate
90.9%
Most Advanced
Phase 4

Trials by Phase

Early Phase 11 (3.7%)
Phase 14 (14.8%)
Phase 24 (14.8%)
Phase 33 (11.1%)
Phase 44 (14.8%)
N/A11 (40.7%)

Trials by Status

terminated27%
completed2074%
recruiting14%
unknown415%

Recent Activity

Clinical Trials (27)

Showing 20 of 27 trialsScroll for more
NCT07370519Phase 2

Topical Application of Lactobacillus Reuteri for Androgenetic Alopecia

Recruiting
NCT01603368Phase 2

Prophylactic Probiotics to Extremely Low Birth Weight Prematures

Completed
NCT04472065Not Applicable

Study of Probiotic Use After Childbirth in Relation to Emotional Well-Being

Completed
NCT04262648Not Applicable

Randomized Placebo-controlled Study of L. Reuteri NCIMB 30351 in GI Functional Disorders and Food Allergy in Newborns

Completed
NCT04116307Phase 4

Enteroadsorbent Polymethylsiloxane vs Probiotic Lactobacillus Reuteri in the Treatment of Rotaviral Gastroenteritis

Completed
NCT03798210Phase 2

Lactobacillus Reuteri ATCC PTA 4659 in Ulcerative Colitis

Unknown
NCT02127814Not Applicable

Lactobacillus Reuteri in the Prevention of Antibiotic Associated-diarrhea and Clostridium Difficile

Completed
NCT01849991Phase 1

Safety and Effect of L. Reuteri on Biomarkers of Inflammation in Healthy Infants With Colic

Completed
NCT03019172Not Applicable

Clinical Trial of L. Reuteri in Urinary Tract Infections in Non Pregnant Women

Completed
NCT01181791Not Applicable

Effects of Lactobacillus Reuteri in Premature Infants

Terminated
NCT02775019Not Applicable

Health Impact of L.Reuteri Consumption in Crew Members of a Naval Ship at Sea

Completed
NCT02124122Phase 1

Safety of Lactobacillus Reuteri in Healthy Children Ages 2 to 5 Years in Peru

Completed
NCT00774163Phase 1

Safety of Lactobacillus Reuteri in Healthy Volunteers

Completed
NCT01593592Not Applicable

Lactobacillus Reuteri in Management of Helicobacter Pylori Infection in Dyspeptic Patients

Completed
NCT01285830Phase 2

Primary Prevention of Allergic Disease in Early Child by Lactobacillus Reuteri

Completed
NCT01836796Not Applicable

Metabolic Effects of Lactobacillus Reuteri DSM 17938 in Type 2 Diabetes

Completed
NCT01531192Phase 4

Comparison of Lactobacillus Reuteri and Nystatin Prophylaxis on Candida Colonization and Infection in Very Low Birth Weight Infants

Completed
NCT01870700Phase 3

Lactobacillus Reuteri in Adult With Functional Chronic Constipation

Completed
NCT01855269Not Applicable

Lactobacillus Reuteri Versus Herbal Drop in the Treatment of Infantile Colic: a Prospective Study

Completed
NCT01531179Phase 3

Lactobacillus Reuteri for Prevention of Necrotizing Enterocolitis in Very Low-birth Weight Infants

Completed

Drug Details

Intervention Type
BIOLOGICAL
Total Trials
27